[
  {
    "_id": {
      "timestamp": 1636472444,
      "machine": 14082257,
      "pid": 5576,
      "increment": 4670147,
      "creationTime": "2021-11-09T15:40:44Z"
    },
    "clinicalStudy": {
      "studyId": "1",
      "studyTitle": "Vaccine Ig Levels in Nasal Mucosa as Measured by Nasal Epithelial Lining Fluid",
      "studyType": "EXPANDED_ACCESS",
      "interventationModel": "Parallel Assignment",
      "investigationalIntervention": [
        {
          "investigationalInterventionId": "1",
          "id": "DRUG",
          "description": "AZD6738",
          "coding": [
            {
              "code": "",
              "codeSystem": "",
              "codeSystemVersion": "",
              "decode": ""
            }
          ]
        }
      ],
      "studyIdentifier": [
        {
          "id": "1",
          "idType": {
            "code": "NCT04298021",
            "name": "ClinicalTrials"
          }
        }
      ],
      "studyObjective": [
        {
          "studyobjectiveId": 1,
          "ObjectiveLevel": "PRIMARY",
          "Objective": [
            {
              "description": "A surveillance study To assess the safety of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients",
              "endpoints": [
                {
                  "OutcomeLevel": "PRIMARY",
                  "endpoint": [
                    {
                      "description": "",
                      "purpose": "SAFETY"
                    }
                  ]
                }
              ]
            }
          ]
        }
      ],
      "studyPhase": "PHASE_1_TRAIL",
      "studyProtocol": {
        "amendments": [
          {
            "amendmentdate": "",
            "version": "V1"
          }
        ],
        "briefTitle": "Umbrella Study of Targeting Agents in Advanced Biliary Tract Cancer",
        "officialTitle": "",
        "protocolId": "C400-1001",
        "publicTitle": "",
        "version": "Draft/Final",
        "sections": [
          "",
          ""
        ]
      },
      "studyTargetIndication": {
        "studyIndicationId": 1,
        "coding": [
          {
            "code": "",
            "codeSystem": "",
            "codeSystemVersion": "",
            "decode": ""
          }
        ],
        "description": "Bile duct cancer",
        "id": 5
      },
      "studyTargetPopulation": [
        {
          "Id": "1",
          "Description": "biliary tract cancer patients who have failed to 1st-line chemotherapy"
        }
      ]
    }
  }
]

